Antigen-specific t-cell activations distinguished by in vivo anti-CD4 antibody treatment

William J. Morrison, Norman J. Kennedy, Halina Offner, Arthur Vandenbark

Research output: Contribution to journalArticle

Abstract

This study identifies activation characteristics of PPD-responsive T-cells that emerge after treatment with anti-CD4 monoclonal antibody (Mab). PPD-stimulated T-cell proliferations, OX40 phenotype and protein tyrosine phosphorylations involving p56lck (pp56lck) were compared to Con A stimulations using T-cells isolated from spleen and draining lymph node of CFA/PPD-immunized rats either untreated or treated in vivo with anti-CD4 Mab. Splenocytes stimulated by concanavalin A (Con A) showed correlated increases in proliferation, levels of pp56lck, and OX40 expression; these parameters were not correlated in splenocytes after PPD-stimulations. T-cells isolated from lymph nodes draining the site of CFA/PPD immunization proliferated in response to stimulation by either PPD or Con A, but only PPD-responsive cells showed correlation to the OX40 activation phenotype and increased levels of pp56lck. CD4+ T-cells isolated from either tissue compartment after anti-CD4 Mab treatments showed higher background and PPD-stimulated proliferations, and expressed lower levels of OX40. In contrast, anti-CD4 Mab treatments reduced (60%) and abolished Con A-stimulated proliferations of splenocytes and lymph node T-cells, respectively. The effects of anti-CD4 Mab treatment on pp56lck levels correlated only to the changes observed for Con A stimulations of splenocytes. These results demonstrate that PPD antigen-specific T-cell populations recovered from different tissue compartments were resistant to in vivo anti-CD4 Mab treatments and did not show the activation changes characteristic of CD4+T-cells after Con A stimulation.

Original languageEnglish (US)
JournalInternational Journal of Immunopharmacology
Volume17
Issue number12
DOIs
StatePublished - 1995

Fingerprint

Tuberculin
Anti-Idiotypic Antibodies
Concanavalin A
Antigens
T-Lymphocytes
Monoclonal Antibodies
Phosphorylation
Therapeutics
Lymph Nodes
Phenotype
Tyrosine
Immunization
Spleen
Cell Proliferation

Keywords

  • CD4
  • OX40
  • p56
  • PPD
  • T-cell
  • tyrosine kinase

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Antigen-specific t-cell activations distinguished by in vivo anti-CD4 antibody treatment. / Morrison, William J.; Kennedy, Norman J.; Offner, Halina; Vandenbark, Arthur.

In: International Journal of Immunopharmacology, Vol. 17, No. 12, 1995.

Research output: Contribution to journalArticle

@article{15d006c520f746ddaade167979e5f745,
title = "Antigen-specific t-cell activations distinguished by in vivo anti-CD4 antibody treatment",
abstract = "This study identifies activation characteristics of PPD-responsive T-cells that emerge after treatment with anti-CD4 monoclonal antibody (Mab). PPD-stimulated T-cell proliferations, OX40 phenotype and protein tyrosine phosphorylations involving p56lck (pp56lck) were compared to Con A stimulations using T-cells isolated from spleen and draining lymph node of CFA/PPD-immunized rats either untreated or treated in vivo with anti-CD4 Mab. Splenocytes stimulated by concanavalin A (Con A) showed correlated increases in proliferation, levels of pp56lck, and OX40 expression; these parameters were not correlated in splenocytes after PPD-stimulations. T-cells isolated from lymph nodes draining the site of CFA/PPD immunization proliferated in response to stimulation by either PPD or Con A, but only PPD-responsive cells showed correlation to the OX40 activation phenotype and increased levels of pp56lck. CD4+ T-cells isolated from either tissue compartment after anti-CD4 Mab treatments showed higher background and PPD-stimulated proliferations, and expressed lower levels of OX40. In contrast, anti-CD4 Mab treatments reduced (60{\%}) and abolished Con A-stimulated proliferations of splenocytes and lymph node T-cells, respectively. The effects of anti-CD4 Mab treatment on pp56lck levels correlated only to the changes observed for Con A stimulations of splenocytes. These results demonstrate that PPD antigen-specific T-cell populations recovered from different tissue compartments were resistant to in vivo anti-CD4 Mab treatments and did not show the activation changes characteristic of CD4+T-cells after Con A stimulation.",
keywords = "CD4, OX40, p56, PPD, T-cell, tyrosine kinase",
author = "Morrison, {William J.} and Kennedy, {Norman J.} and Halina Offner and Arthur Vandenbark",
year = "1995",
doi = "10.1016/0192-0561(95)00076-3",
language = "English (US)",
volume = "17",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - Antigen-specific t-cell activations distinguished by in vivo anti-CD4 antibody treatment

AU - Morrison, William J.

AU - Kennedy, Norman J.

AU - Offner, Halina

AU - Vandenbark, Arthur

PY - 1995

Y1 - 1995

N2 - This study identifies activation characteristics of PPD-responsive T-cells that emerge after treatment with anti-CD4 monoclonal antibody (Mab). PPD-stimulated T-cell proliferations, OX40 phenotype and protein tyrosine phosphorylations involving p56lck (pp56lck) were compared to Con A stimulations using T-cells isolated from spleen and draining lymph node of CFA/PPD-immunized rats either untreated or treated in vivo with anti-CD4 Mab. Splenocytes stimulated by concanavalin A (Con A) showed correlated increases in proliferation, levels of pp56lck, and OX40 expression; these parameters were not correlated in splenocytes after PPD-stimulations. T-cells isolated from lymph nodes draining the site of CFA/PPD immunization proliferated in response to stimulation by either PPD or Con A, but only PPD-responsive cells showed correlation to the OX40 activation phenotype and increased levels of pp56lck. CD4+ T-cells isolated from either tissue compartment after anti-CD4 Mab treatments showed higher background and PPD-stimulated proliferations, and expressed lower levels of OX40. In contrast, anti-CD4 Mab treatments reduced (60%) and abolished Con A-stimulated proliferations of splenocytes and lymph node T-cells, respectively. The effects of anti-CD4 Mab treatment on pp56lck levels correlated only to the changes observed for Con A stimulations of splenocytes. These results demonstrate that PPD antigen-specific T-cell populations recovered from different tissue compartments were resistant to in vivo anti-CD4 Mab treatments and did not show the activation changes characteristic of CD4+T-cells after Con A stimulation.

AB - This study identifies activation characteristics of PPD-responsive T-cells that emerge after treatment with anti-CD4 monoclonal antibody (Mab). PPD-stimulated T-cell proliferations, OX40 phenotype and protein tyrosine phosphorylations involving p56lck (pp56lck) were compared to Con A stimulations using T-cells isolated from spleen and draining lymph node of CFA/PPD-immunized rats either untreated or treated in vivo with anti-CD4 Mab. Splenocytes stimulated by concanavalin A (Con A) showed correlated increases in proliferation, levels of pp56lck, and OX40 expression; these parameters were not correlated in splenocytes after PPD-stimulations. T-cells isolated from lymph nodes draining the site of CFA/PPD immunization proliferated in response to stimulation by either PPD or Con A, but only PPD-responsive cells showed correlation to the OX40 activation phenotype and increased levels of pp56lck. CD4+ T-cells isolated from either tissue compartment after anti-CD4 Mab treatments showed higher background and PPD-stimulated proliferations, and expressed lower levels of OX40. In contrast, anti-CD4 Mab treatments reduced (60%) and abolished Con A-stimulated proliferations of splenocytes and lymph node T-cells, respectively. The effects of anti-CD4 Mab treatment on pp56lck levels correlated only to the changes observed for Con A stimulations of splenocytes. These results demonstrate that PPD antigen-specific T-cell populations recovered from different tissue compartments were resistant to in vivo anti-CD4 Mab treatments and did not show the activation changes characteristic of CD4+T-cells after Con A stimulation.

KW - CD4

KW - OX40

KW - p56

KW - PPD

KW - T-cell

KW - tyrosine kinase

UR - http://www.scopus.com/inward/record.url?scp=0029555120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029555120&partnerID=8YFLogxK

U2 - 10.1016/0192-0561(95)00076-3

DO - 10.1016/0192-0561(95)00076-3

M3 - Article

VL - 17

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 12

ER -